New Horizons in Menopause, Menopausal Hormone Therapy, and Alzheimer’s Disease: Current Insights and Future Directions
Comment: The argument for a ‘window of opportunity’—where MHT might actually be neuroprotective if timed correctly—is compelling. However I remain cautious about broadly applying this as I tend to always consider the risk side of the equation with synthetic medications. The clinical management of Alzheimer’s disease (AD) prevention has long operated on the assumption that […]
